| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2022 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 3 | 12/29/2024 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| 2023 | 2022 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 3 | 12/13/2022 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $745,553 ) |
| 2022 | 2022 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 001 | 3 | 9/2/2022 | NON-COMPETING CONTINUATION | $745,553 |
| 2022 | 2020 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 1 | 4/8/2022 | NEW | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $751,545 ) |
| 2021 | 2021 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 001 | 2 | 8/21/2021 | EXTENSION WITH OR WITHOUT FUNDS | $751,545 |
| 2021 | 2020 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 1 | 4/22/2021 | NEW | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $224,923 ) |
| 2020 | 2020 | MINNESOTA HEALTHSOLUTIONS CORPORATION | 861 E HENNEPIN AVE STE 440 | MINNEAPOLIS | MN | 55414 | HENNEPIN | USA | Lung Diseases Research | 000 | 1 | 8/27/2020 | NEW | $224,923 |
|
|